One of the MYC family genes, MYC, MYCL or MYCN, is amplified and overexpressed in ~20% in a mutually exclusive manner and represents the most prominent activating oncogene alteration in SCLC [2, 4, 6]. This evidence concerns the gene MYCL and small cell lung carcinoma.